Biomedical bust

It's not just the growth rate of biomedical funding that's slowing; the total number of dollars seems to be decreasing as well, says a linkurl:study;http://jama.ama-assn.org/cgi/content/full/303/2/137?home in this week's Journal of the American Medical Association. Image: Refracted Moment's, Flickr To make matters worse, the funding downturn also corresponds to one of the biomedical industry's most stagnant periods in productivity, measured by the number of new drugs approved by the US Food a

Katherine Bagley
Jan 11, 2010
It's not just the growth rate of biomedical funding that's slowing; the total number of dollars seems to be decreasing as well, says a linkurl:study;http://jama.ama-assn.org/cgi/content/full/303/2/137?home in this week's Journal of the American Medical Association.
Image: Refracted Moment's, Flickr
To make matters worse, the funding downturn also corresponds to one of the biomedical industry's most stagnant periods in productivity, measured by the number of new drugs approved by the US Food and Drug Administration, the report notes. linkurl:E. Ray Dorsey,;http://www.urmc.rochester.edu/web/index.cfm?event=doctor.profile.show&person_id=1002735 a neurologist at the University of Rochester Medical Center, New York, and colleagues analyzed biomedical funding records from federal, state and local governments, foundations, and industry. All values were adjusted to 2008 dollar levels using the biomedical research and development price index (BRDPI). They then compared their results to a similar 2005 study they did on biomedical funding from 1994 to 2003. At first glance, funding in biomedical research during...



Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?